Literature DB >> 25572840

Phytochemicals and their potential usefulness in inflammatory bowel disease.

Sahil J Somani1, Ketan P Modi, Anuradha S Majumdar, Bhakti N Sadarani.   

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract with unclear etiology, namely ulcerative colitis and Crohn's disease. Various drug therapies including aminosalicylates and immunomodulators have been approved for use; they have shown to produce diverse side effects. To overcome these limitations of the current therapeutics for IBD, extensive research is underway to identify drugs that are effective and free of undesirable side effects. Recently, various naturally occurring phytochemicals that cover a wide range of chemical entities such as polyphenols, terpeniods, flavonoids, and alkaloids have received attention as alternative candidates for IBD therapy. These phytochemicals act by modulating the immune response, various transcription factors, or reduce cytokine secretion. This review summarizes the findings of recent studies on phytochemicals as therapeutic agents in the management of IBD.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Crohn's disease; flavonoids; phytochemicals; terpenoids; ulcerative colitis

Mesh:

Substances:

Year:  2015        PMID: 25572840     DOI: 10.1002/ptr.5271

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  24 in total

1.  Principles of pharmacological research of nutraceuticals.

Authors:  Ruth Andrew; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2017-06       Impact factor: 8.739

2.  Refractory pouchitis improves after administration of the green tea polyphenol EGCG: a retrospective review.

Authors:  Minesh Mehta; Shifat Ahmed; Gerald Dryden
Journal:  Int J Colorectal Dis       Date:  2017-09-20       Impact factor: 2.571

3.  Green tea EGCG effectively alleviates experimental colitis in middle-aged male mice by attenuating multiple aspects of oxi-inflammatory stress and cell cycle deregulation.

Authors:  Bhawna Diwan; Rohit Sharma
Journal:  Biogerontology       Date:  2022-07-02       Impact factor: 4.277

Review 4.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

5.  Potential usefulness of methyl gallate in the treatment of experimental colitis.

Authors:  María Laura Anzoise; Angeles Rodríguez Basso; Julieta Sofía Del Mauro; Andrea Carranza; Graciela López Ordieres; Susana Gorzalczany
Journal:  Inflammopharmacology       Date:  2017-11-07       Impact factor: 4.473

Review 6.  Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?

Authors:  Susana Almeida; Marco G Alves; Mário Sousa; Pedro F Oliveira; Branca M Silva
Journal:  Neurotox Res       Date:  2016-01-08       Impact factor: 3.911

7.  Capparis Spinosa L. promotes anti-inflammatory response in vitro through the control of cytokine gene expression in human peripheral blood mononuclear cells.

Authors:  Mouna Moutia; Khadija El Azhary; Anass Elouaddari; Abdellah Al Jahid; Jamal Jamal Eddine; Fouad Seghrouchni; Norddine Habti; Abdallah Badou
Journal:  BMC Immunol       Date:  2016-08-02       Impact factor: 3.615

Review 8.  Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls.

Authors:  Anouk Kaulmann; Torsten Bohn
Journal:  Oxid Med Cell Longev       Date:  2016-07-10       Impact factor: 6.543

Review 9.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

10.  Allium sativum L. regulates in vitro IL-17 gene expression in human peripheral blood mononuclear cells.

Authors:  Mouna Moutia; Fouad Seghrouchni; Omar Abouelazz; Anass Elouaddari; Abdellah Al Jahid; Abdelhalim Elhou; Sellama Nadifi; Jamal Jamal Eddine; Norddine Habti; Abdallah Badou
Journal:  BMC Complement Altern Med       Date:  2016-09-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.